Eye care specialist Alcon has launched the Clareon family of intraocular lenses (IOLs) in the U.S.
The company says Clareon clarity is born out of a glistening-free IOL material that has among the lowest levels of haze and subsurface nanoglistenings (SSNGs) compared to leading competitor IOLs.
Ian Bell, president, global business & innovation, Alcon, said: “We are proud to offer our latest IOL technology in the U.S. and other countries across the globe. At Alcon, we are consistently pushing the boundaries to deliver transformational innovation to cataract surgeons and their patients. Clareon is the result of robust R&D efforts at every level—inventive material science, advanced manufacturing techniques and novel delivery systems—to deliver exceptional, long-lasting clarity.”
The Clareon portfolio leverages many of the same design characteristics and optics as Alcon’s IOLs to help deliver the outcomes surgeons expect. Clareon offers sharp, crisp vision with an edge designed to help reduce glare and posterior capsular opacification. The lens’ Stableforce Haptics provide superior axial and rotational stability. Clareon has been extensively researched, with inclusion in 30 published studies worldwide. Clareon Monofocal and Clareon Toric IOLs have already been implanted in more than one million eyes across more than 70 countries.
Clareon IOLs are inserted using the reusable Clareon Monarch IVDelivery System, which provides precise implantation and was designed specifically for the new Clareon material. Clareon Monofocal is also available in the automated, single-use delivery system, AutonoMe.
Dr. Samuel H. Lee, MD, ophthalmologist, Sacramento, CA, said: “As one of the investigators for the Clareon pivotal trial, I was immediately impressed with the clarity of the new IOL material, delivery system and the consistent refractive outcomes. Today, the clarity of Clareon persists four years later in my trial patients, with the optic performance that I expect from Alcon IOLs, as well as continued high patient satisfaction.”
Clareon Monofocal, Clareon PanOptix, Clareon PanOptix Toric, Clareon Vivity and Clareon Vivity Toric IOLs are now available in the U.S. Clareon PanOptix offers patients the possibility of 20/20 vision at distance (far), intermediate (at arm’s length) and near (up close), with continuous vision of 20/25 or better. Clareon Vivity is a non-diffractive extended depth of focus lens with wavefront-shaping X-WAVE technology, delivering monofocal-quality distance with excellent intermediate and functional near vision and with a monofocal visual disturbance profile.
Clareon Toric will be available in the U.S. later this year. Alcon will be rolling out the Clareon family of IOLs in international markets throughout 2022 and 2023.
